On-Demand Webcast

Share

Program Content

Activities

  • Advances in Relapsed/Refractory Multiple Myeloma
    New Advances in Relapsed/Refractory Multiple Myeloma: Current Guidance and Future Perspectives
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 14, 2020

    Expires: September 13, 2021

Faculty

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Mayo Clinic
Rochester, Minnesota

cover img faculity

Natalie S. Callander, MD

Professor of Medicine
School of Medicine and Public Health
University of Wisconsin
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin

Provided by

ProCE Banner

Supporters

GlaxoSmithKline LLC

Sanofi Genzyme Corp